FMF patients routinely presenting to our outpatient clinic are regularly monitored for subclinical disease activity via measurement of classical inflammatory markers (CRP, SAA, and ESR) and additionally with the routinely available marker S100A8/A9. This evidence concerns the gene CRP and familial Mediterranean fever.